These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22923346)

  • 21. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
    Wang R; Sun H; Ren H; Wang G
    Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
    Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
    Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse engineering Lewy bodies: how far have we come and how far can we go?
    Fares MB; Jagannath S; Lashuel HA
    Nat Rev Neurosci; 2021 Feb; 22(2):111-131. PubMed ID: 33432241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.
    Mori A; Imai Y; Hattori N
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of alpha-synuclein aggregation by dopamine: a review.
    Leong SL; Cappai R; Barnham KJ; Pham CL
    Neurochem Res; 2009 Oct; 34(10):1838-46. PubMed ID: 19444607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
    Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
    Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine promotes the neurodegenerative potential of β-synuclein.
    Raina A; Leite K; Guerin S; Mahajani SU; Chakrabarti KS; Voll D; Becker S; Griesinger C; Bähr M; Kügler S
    J Neurochem; 2021 Mar; 156(5):674-691. PubMed ID: 32730640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.
    Volpicelli-Daley LA; Luk KC; Patel TP; Tanik SA; Riddle DM; Stieber A; Meaney DF; Trojanowski JQ; Lee VM
    Neuron; 2011 Oct; 72(1):57-71. PubMed ID: 21982369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells.
    Deshayes N; Arkan S; Hansen C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
    Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
    Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC; Hyde EG; Trojanowski JQ; Lee VM
    Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular chaperones and associated cellular clearance mechanisms against toxic protein conformers in Parkinson's disease.
    Hinault MP; Farina-Henriquez-Cuendet A; Goloubinoff P
    Neurodegener Dis; 2011; 8(6):397-412. PubMed ID: 21411979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The central theme of Parkinson's disease: α-synuclein.
    Ozansoy M; Başak AN
    Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.
    Emmer KL; Waxman EA; Covy JP; Giasson BI
    J Biol Chem; 2011 Oct; 286(40):35104-18. PubMed ID: 21846727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.
    Luk KC; Song C; O'Brien P; Stieber A; Branch JR; Brunden KR; Trojanowski JQ; Lee VM
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20051-6. PubMed ID: 19892735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of α-synuclein in neurodegenerative diseases: from molecular pathways in disease to therapeutic approaches.
    Al-Mansoori KM; Hasan MY; Al-Hayani A; El-Agnaf OM
    Curr Alzheimer Res; 2013 Jul; 10(6):559-68. PubMed ID: 23899170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.
    Gao HM; Kotzbauer PT; Uryu K; Leight S; Trojanowski JQ; Lee VM
    J Neurosci; 2008 Jul; 28(30):7687-98. PubMed ID: 18650345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic Insight into the Binding Profile of DCVJ and α-Synuclein Fibril Revealed by Multiscale Simulations.
    Kuang G; Murugan NA; Ågren H
    ACS Chem Neurosci; 2019 Jan; 10(1):610-617. PubMed ID: 30277753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.
    Xu MM; Ryan P; Rudrawar S; Quinn RJ; Zhang HY; Mellick GD
    Acta Pharmacol Sin; 2020 Apr; 41(4):483-498. PubMed ID: 31586134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.